Kawano, Noriaki
Wada, Hideo
Uchiyama, Toshimasa
Kawasugi, Kazuo
Madoiwa, Seiji
Takezako, Naoki
Suzuki, Kei
Seki, Yoshinobu
Ikezoe, Takayuki
Hattori, Tsuyoshi
Okamoto, Kohji
Article History
Received: 28 October 2019
Accepted: 28 January 2020
First Online: 7 February 2020
Ethics approval and consent to participate
: Approval for this study (No. 18–44) was obtained from the appropriate ethics committees and institutional review boards of Miyazaki Prefectural Miyazaki Hospital.
: Not applicable.
: Asahi Kasei Pharma Corporation absorbed expense for the analysis and the native check of manuscript. NK has no grant and personal fee. HW received grants and personal fees from Asahi Kasei Pharma Corporation and Japan Blood Products Organization outside the present work. TU, SM, NT, KS, YS, and KO received personal fees from Asahi Kasei Pharma Corporation outside the present work. KK and TI received grants and personal fees from Asahi Kasei Pharma Corporation outside the present work. TH is an employee of Asahi Kasei Pharma Corporation.